Last update 20 Mar 2025

Octadecyloxyethyl-tenofovir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ODE-TFV
Target
RT
Action
inhibitors
Mechanism
RT inhibitors(Reverse transcriptase inhibitors)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesDigestive System Disorders+ [1]
Active Indication
Hepatitis BHIV Infections
Inactive Indication
Hepatitis B, Chronic
Originator Organization
Chinese Academy of Medical SciencesChinese Academy of Medical Sciences
Active Organization
Agenix Ltd.Xinkaiyiyao Science & Technology Shanghai Co. Ltd.Chinese Academy of Medical SciencesChinese Academy of Medical Sciences
Inactive Organization
Institute of Pharmaceutical Biotechnology, Chinese Academy of Medical SciencesXinkai Medicine and Chemical Intermediates (Shanghai) Co., Ltd.
Drug Highest PhasePhase 1
First Approval Date-
RegulationSpecial Review Project (China)
Login to view timeline

Related

1
Clinical Trials associated with Octadecyloxyethyl-tenofovir
CTR20180848
/ CompletedPhase 1
替诺福韦十八烷氧乙酯在健康受试者中单次给药的安全性和药代动力学Ia期临床研究
[Translation] Phase Ia clinical study on the safety and pharmacokinetics of single-dose tenofovir disoproxil fumarate in healthy subjects
100 Clinical Results associated with Octadecyloxyethyl-tenofovir
Login to view more data
100 Translational Medicine associated with Octadecyloxyethyl-tenofovir
Login to view more data
100 Patents (Medical) associated with Octadecyloxyethyl-tenofovir
Login to view more data
100 Deals associated with Octadecyloxyethyl-tenofovir
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis BPhase 1-
Agenix Ltd.
-
HIV InfectionsPhase 1
China
Chinese Academy of Medical SciencesChinese Academy of Medical Sciences
-
HIV InfectionsPhase 1
China
Xinkaiyiyao Science & Technology Shanghai Co. Ltd.
-
HIV InfectionsPhase 1-
Agenix Ltd.
-
Hepatitis B, ChronicDiscovery
China
Xinkai Medicine and Chemical Intermediates (Shanghai) Co., Ltd.
12 Dec 2019
Hepatitis B, ChronicDiscovery
China
Xinkaiyiyao Science & Technology Shanghai Co. Ltd.
12 Dec 2019
Hepatitis B, ChronicDiscovery
China
Institute of Pharmaceutical Biotechnology, Chinese Academy of Medical Sciences
12 Dec 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free